Operations

As competition in the life sciences industry increases, and payors restrict reimbursement, more pharmaceutical, biotech, and medical product companies are trying to maximize profits through operational improvements to save time, money and resources.

The ACMA can help with the increasing complexity of the healthcare landscape, such as the shift to greater scrutiny and visibility in the area of medical affairs, sales and market access.

We have decades of experience in all aspects of pharma/biotech operations, allowing us to help clients identify opportunities for enhanced market access, efficiency improvement, and cost reduction throughout the entire drug development and launch cycle. We have served more than 250+ pharmaceutical, biotech, and medical device clients giving us a detailed understanding of all industry trends and challenges.

The ACMA takes a hands-on approach to working with clients, creating practical strategies that generate real impact.

To sustain long-term improvement, we emphasize helping clients build their internal capabilities, providing tailored training programs for all organizational levels.

The ACMA also has developed a set of digital tools specifically for pharmaceutical operations, focusing on enhancing data and content management which can ultimately help external and internal stakeholder engagement.